We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06293898
Title Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SystImmune Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
SystImmune Recruiting Center RECRUITING New York New York 10469 United States Details
SystImmune Recruiting Center RECRUITING New York New York 11042 United States Details
SystImmune Recruiting Center RECRUITING New York New York 11967 United States Details
SystImmune Recruiting Center RECRUITING Nashville Tennessee 37203 United States Details
SystImmune Recruiting Site RECRUITING Houston Texas 77030 United States Details
SystImmune Recruiting Center RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field